Although these three significant pathways might be the mechanisms of the activation of CD4+ T cells induced by the hub FRGs in GC, further studies are needed to provide conclusive evidence for the specific mechanisms in the tumor microenvironment (TME). The gene discussed is CD4; the disease is neoplasm.